Optimisation and Developability banner

Tailoring a molecule’s properties to improve its binding, specificity, half-life, or therapeutic index will greatly improve its chance of success in the clinic. Similarly, assessing and predicting a molecule’s developability will improve its candidacy for advancement into the clinic. The 14th Annual Optimisation & Developability conference will present strategies to optimise drug properties, design molecules with the right developability properties, assess and predict stability and manufacturability, etc., using a toolbox of molecular dynamics, simulation, in silico prediction, and AI approaches.

For more details on the conference, please contact:

Mimi Langley
Senior Conference Director
Cambridge Healthtech Institute
Phone: (+1) 781-972-5439
Email: mlangley@healthtech.com

For sponsorship information, please contact:

Companies A-K
Jason Gerardi
Sr. Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-5452
Email: jgerardi@healthtech.com

Companies L-Z
Ashley Parsons
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-972-1340
Email: ashleyparsons@healthtech.com